Información del artículo
El Texto completo está disponible en PDF
References
[1.]
A. Guarga, R. Pla, J. Benet, A. Pozuelo.
Planificación de los servicios de alta especialización en Cataluña.
Med Clin (Barc), 131 (2008), pp. 55-59
[2.]
E. Vieta.
Bipolar Units and Programmes: Are they really needed?.
World Psychiatry. En prensa, (2011),
[3.]
R. Tabarés-Seisdedos, I. Mata, T. Escámez, E. Vieta, J.M. López-Ilundain, J. Salazar, et al.
Evidence for association between structural variants in lissencephaly-related genes and executive deficits in schizophrenia or bipolar patients from a Spanish isolate population.
Psychiatr Genet, 18 (2008), pp. 313-317
[4.]
E. Vieta, M.J. Martínez-De-Osaba, F. Colom, A. Martínez-Arán, A. Benabarre, C. Gastó.
Enhanced corticotropin response to corticotropin-releasing hormone as a predictor of mania in euthymic bipolar patients.
Psychol Med, 29 (1999), pp. 971-978
[5.]
A.R. Rosa, B.N. Frey, A.C. Andreazza, K.M. Ceresér, A.B. Cunha, J. Quevedo, et al.
Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder.
Neurosci Lett, 407 (2006), pp. 146-150
[6.]
A. Benabarre, E. Vieta, F. Martín, F. Lomeña, A. Martínez-Aràn, F. Colom, et al.
Clinical value of 99mTc-HMPAO SPECT in depressed bipolar I patients.
Psychiatry Res, 132 (2004), pp. 285-289
[7.]
M.L. Phillips, E. Vieta.
Identifying functional neuroimaging biomarkers of bipolar disorder: toward DSM-V.
Schizophr Bull, 33 (2007), pp. 893-904
[8.]
A. Martínez-Arán, E. Vieta, M. Reinares, F. Colom, C. Torrent, J. Sánchez-Moreno, et al.
Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder.
Am J Psychiatry, 161 (2004), pp. 262-270
[9.]
C. Torrent, A. Martínez-Arán, C. Daban, J. Sánchez-Moreno, M. Comes, J.M. Goikolea, et al.
Cognitive impairment in bipolar II disorder.
Br J Psychiatry, 189 (2006), pp. 254-259
[10.]
J. Sanchez-Moreno, A. Martinez-Aran, F. Colom, J. Scott, R. Tabares-Seisdedos, G. Sugranyes, et al.
Neurocognitive dysfunctions in euthymic bipolar patients with and without prior history of alcohol use.
J Clin Psychiatry, 70 (2009), pp. 1120-1127
[11.]
C.M. Bonnín, A. Martínez-Arán, C. Torrent, I. Pacchiarotti, A.R. Rosa, C. Franco, et al.
Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study.
J Affect Disord, 121 (2010), pp. 156-160
[12.]
E. Vieta, X. Carné.
The use of placebo in clinical trials on bipolar disorder: a new approach for an old debate.
Psychother Psychosom, 74 (2005), pp. 10-16
[13.]
A. Martinez-Arán, E. Vieta, K.N. Chengappa, S. Gershon, J. Mullen, B. Paulsson.
Reporting outcomes in clinical trials for bipolar disorder: a commentary and suggestions for change.
Bipolar Disord, 10 (2008), pp. 566-579
[14.]
E. Vieta, C. Gastó, A. Otero, E. Nieto, J. Vallejo.
Differential features between bipolar I and bipolar II disorder.
Compr Psychiatry, 38 (1997), pp. 98-101
[15.]
F. Colom, E. Vieta, C. Daban, I. Pacchiarotti, J. Sánchez-Moreno.
Clinical and therapeutic implications of predominant polarity in bipolar disorder.
J Affect Disord, 93 (2006), pp. 13-17
[16.]
E. Vieta, M.L. Phillips.
Deconstructing bipolar disorder: a critical review of its diagnostic validity and a proposal for DSM-V and ICD-11.
Schizophr Bull, 33 (2007), pp. 886-892
[17.]
E. Vieta, T. Suppes.
Bipolar II disorder: arguments for and against a distinct diagnostic entity.
Bipolar Disord, 10 (2008), pp. 163-178
[18.]
F. Colom, E. Vieta.
The road to DSM-V Bipolar disorder episode and course specifiers.
Psychopathology, 42 (2009), pp. 209-218
[19.]
E. Vieta, F. Colom, B. Corbella, A. Martínez-Arán, M. Reinares, A. Benabarre, et al.
Clinical correlates of psychiatric comorbidity in bipolar I patients.
Bipolar Disord, 3 (2001), pp. 253-258
[20.]
M. Tohen, E. Vieta, A. Gonzalez-Pinto, C. Reed, D. Lin.
Euro- pean Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) Advisory Board Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania.
J Clin Psychiatry, 7 (2010), pp. 255-261
[21.]
J. Angst, T.D. Meyer, R. Adolfsson, P. Skeppar, M. Carta, F. Benazzi, et al.
Hypomania: a transcultural perspective.
World Psychiatry, 9 (2010), pp. 41-49
[22.]
E. Vieta, J.M. Goikolea, B. Corbella, A. Benabarre, M. Reinares, G. Martínez, et al.
Group for the Study of Risperidone in Affective Disorders (GSRAD) Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.
J Clin Psychiatry, 62 (2001), pp. 818-825
[23.]
E. Vieta, A. Martinez-Arán, J.M. Goikolea, C. Torrent, F. Colom, A. Benabarre, et al.
A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.
J Clin Psychiatry, 63 (2002), pp. 508-512
[24.]
M. Tohen, E. Vieta, J. Calabrese, T.A. Ketter, G. Sachs, C. Bowden, et al.
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
Arch Gen Psychiatry, 60 (2003), pp. 1079-1088
[25.]
E. Vieta, N. Cruz, J. García-Campayo, R. de Arce, J. Manuel Crespo, V. Vallès, et al.
A double-blind, randomized, placebocontrolled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.
Int J Neuropsychopharmacol, 11 (2008), pp. 445-452
[26.]
E. Vieta, C. T’joen, R.D. McQuade, W.H. Carson Jr., R.N. Marcus, R. Sanchez, et al.
Efficacy of adjunctive aripiprazole to eit- her valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebocontrolled study.
Am J Psychiatry, 165 (2008), pp. 1316-1325
[27.]
E. Vieta, T. Suppes, I. Eggens, I. Persson, B. Paulsson, M. Brecher.
Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
J Affect Disord, 109 (2008), pp. 251-263
[28.]
M.L. Van der Loos, P.G. Mulder, E.G. Hartong, M.B. Blom, A.C. Vergouwen, H.J. De Keyzer, et al.
LamLit Study Group. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo- controlled trial.
J Clin Psychiatry, 70 (2009), pp. 223-231
[29.]
E. Vieta, T. Ramey, D. Keller, P.A. English, A.D. Loebel, J. Miceli.
Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study.
J Psychopharmacol, 24 (2010), pp. 547-558
[30.]
R.S. El Mallakh, E. Vieta, L. Rollin, R. Marcus, W.H. Carson, R. McQuade.
A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007).
Eur Neuropsychopharmacol, 20 (2010), pp. 776-783
[31.]
E. Vieta, I.F. Nuamah, P. Lim, E.C. Yuen, J.M. Palumbo, D.W. Hough, et al.
A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder.
Bipolar Disord, 12 (2010), pp. 230-243
[32.]
E. Vieta, J. Locklear, O. Günther, M. Ekman, C. Miltenburger, M.L. Chatterton, et al.
Treatment options for bipolar depression: a systematic review of randomized, controlled trials.
J Clin Psychopharmacol, 30 (2010), pp. 579-590
[33.]
F. Colom, E. Vieta, A. Martinez-Aran, M. Reinares, J.M. Goikolea, A. Benabarre, et al.
A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission.
Arch Gen Psychiatry, 60 (2003), pp. 402-407
[34.]
J. Scott, F. Colom, E. Vieta.
A meta-analysis of relapse rates with adjunctive psychological therapies compared to usual psychiatric treatment for bipolar disorders.
Int J Neuropsychopharmacol, 10 (2007), pp. 123-129
[35.]
M. Reinares, F. Colom, J. Sánchez-Moreno, C. Torrent, A. Martínez-Arán, M. Comes, et al.
Impact of caregiver group psychoeducation on the course and outcome of bipolar patients in remission: a randomized controlled trial.
Bipolar Disord, 10 (2008), pp. 511-519
[36.]
J. Scott, F. Colom, E. Popova, A. Benabarre, N. Cruz, M. Valenti, et al.
Long-term mental health resource utilization and cost of care following group psychoeducation or unstructured group support for bipolar disorders: a cost-benefit analysis.
J Clin Psychiatry, 70 (2009), pp. 378-386
[37.]
F. Colom, E. Vieta, J. Sánchez-Moreno, R. Palomino-Otiniano, M. Reinares, J.M. Goikolea, et al.
Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial.
Br J Psychiatry, 194 (2009), pp. 260-265
[38.]
C. Torrent, E. Vieta, J.A. Crespo, A. Gonzalez-Pinto, J. del Valle, J.M. Olivares, et al.
Barcelona Bipolar Eating Disorder Scale (BEDS): a self-administered scale for eating distur- bances in bipolar patients.
Actas Esp Psiquiatr, 32 (2004), pp. 127-131
[39.]
E. Vieta, J. Sánchez-Moreno, A. Bulbena, L. Chamorro, J.L. Ramos, J. Artal, et al.
EDHIPO (Hypomania Detection Study) Group Cross validation with the mood disorder questionnaire (MDQ) of an instrument for the detection of hypomania in Spanish: the 32 item hypomania symptom check list (HCL-32).
J Affect Disord, 101 (2007), pp. 43-55
[40.]
E. Vieta, A. Cieza, G. Stucki, S. Chatterji, M. Nieto, J. Sánchez-Moreno, et al.
Developing core sets for persons with bipolar disorder based on the International Classification of Functioning Disability and Health.
Bipolar Disord, 9 (2007), pp. 16-24
[41.]
A. Martinez-Aran, E. Vieta, C. Torrent, J. Sanchez-Moreno, J.M. Goikolea, M. Salamero.
Functional outcome in bipo- lar disorder: the role of clinical and cognitive factors.
Bipolar Disord, 9 (2007), pp. 103-113
[42.]
A.R. Rosa, J. Sánchez-Moreno, A. Martínez-Aran, M. Salamero, C. Torrent, M. Reinares, et al.
Validity and reliability of the Func- tioning Assessment Short Test (FAST) in bipolar disorder.
Clin Pract Epidemiol Ment Health, 3 (2007), pp. 5
[43.]
A.R. Rosa, C.M. Bonnin, L. Mazzarini, B. Amann, F. Kapczinski, E. Vieta.
Predictores clínicos del funcionamiento interpersonal en pacientes bipolares.
Rev Psiquiatr Salud Ment (Barc), 2 (2009), pp. 83-88
[44.]
F. Colom, E. Vieta, A. Martínez-Arán, M. Reinares, A. Benabarre, C. Gastó.
Clinical factors associated with treatment noncompliance in euthymic bipolar patients.
J Clin Psychiatry, 61 (2000), pp. 549-555
[45.]
E. Vieta.
New guidelines for bipolar disorders.
World J Biol Psychiatry, 10 (2009), pp. 82-84
[46.]
H. Grunze, E. Vieta, G.M. Goodwin, C. Bowden, R.W. Licht, H.J. Moller, et al.
The World Federation of Societies of Biological Psychia- try (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania.
World J Biol Psychiatry, 10 (2009), pp. 85-116
[47.]
G. Goodwin, FleischhackerW, C. Arango, P. Baumann, M. Davidson, M. De Hert, et al.
Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting March 2008.
Nice Eur Neuropsychopharmacol, 19 (2009), pp. 520-532
[48.]
L.N. Yatham, S.H. Kennedy, A. Schaffer, S.V. Parikh, S. Beaulieu, C. O’Donovan, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.
Bipolar Disord, 11 (2009), pp. 225-255
[49.]
H. Grunze, E. Vieta, G.M. Goodwin, C. Bowden, R.W. Licht, H.J. Möller, et al.
WFSBP Task Force On Treatment Guidelines For Bipolar Disorders The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.
World J Biol Psychiatry, 11 (2010), pp. 81-109
[50.]
Vieta E, Murru A, Pueyo MJ. Guia sobre el maneig del trastorn bipolar a Catalunya. Barcelona: Agència d’Informació, Avaluació i Qualitat en Salut. Servei Català de la Salut. Departament de Salut. Generalitat de Catalunya; 2010.
[51.]
A.M. Nivoli, F. Colom, A. Murru, I. Pacchiarotti, P. Castro-Loli, A. González-Pinto, et al.
New treatment guidelines for acute bipolar depression: A systematic review.
J Affect Disord, (2010),
[52.]
Vieta E. The European Network for Bipolar Disorder. ECNP matters, 2008; 14. Available from: http://matters.ecnp.nl/number14/network.shtml.
[53.]
E. Vieta.
Progress in research at the CIBERSAM's affective disorders programme of the University of Barcelona Hospital Clinic.
Eur J Psychiat, 23 (2009), pp. 174-180
[54.]
R. Tabarés-Seisdedos, T. Escámez, J.A. Martínez-Giménez, V. Balanzá, J. Salazar, G. Selva, et al.
Variations in genes regulating neuronal migration predict reduced prefrontal cognition in schizophrenia and bipolar subjects from mediterranean Spain: a preliminary study.
Neuroscience, 139 (2006), pp. 1289-1300
[55.]
M. Mur, M.J. Portella, A. Martínez-Arán, J. Pifarré, E. Vieta.
Persistent neuropsychological deficit in euthymic bipolar patients: executive function as a core deficit.
J Clin Psychiatry, 68 (2007), pp. 1078-1086
[56.]
A. González-Pinto, P. Vega, B. Ibáñez, F. Mosquera, S. Barbeito, M. Gutiérrez, et al.
Impact of cannabis and other drugs on age at onset of psychosis.
J Clin Psychiatry, 69 (2008), pp. 1210-1216
[57.]
C. De Dios, E. Ezquiaga, A. Garcia, B. Soler, E. Vieta.
Time spent with symptoms in a cohort of bipolar disorder outpatients in Spain: A prospective, 18-month follow-up study.
J Affect Disord, (2009),
[58.]
C.C. Avila, M. Cabello, A. Cieza, E. Vieta, J.L. Ayuso-Mateos.
Functioning and disability in bipolar disorders: a systematic review of literature using the ICF as a reference.
Bipolar Disord, 12 (2010), pp. 473-482
[59.]
K.N. Fountoulakis, E. Vieta, J. Sanchez-Moreno, S.G. Kaprinis, J.M. Goikolea, G.S. Kaprinis.
Treatment guidelines for bipo- lar disorder: a critical review.
J Affect Disord, 86 (2005), pp. 1-10
[60.]
J. Angst, R. Adolfsson, F. Benazzi, A. Gamma, E. Hantouche, T.D. Meyer, et al.
The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients.
J Affect Disord, 88 (2005), pp. 217-233
[61.]
C. Henry, K. M’Baïlara, R. Poinsot, A.A. Casteret, F. Sorbara, M. Leboyer, et al.
Evidence for two types of bipolar depres- sion using a dimensional approach.
Psychother Psychosom, 76 (2007), pp. 325-331
[62.]
A. Martinez-Aran, J. Scott, F. Colom, C. Torrent, R. Tabares-Seisdedos, C. Daban, et al.
Treatment nonadherence and neurocognitive impairment in bipolar disorder.
J Clin Psychiatry, 70 (2009), pp. 1017-1023
[63.]
A.R. Rosa, N. Cruz, C. Franco, J.M. Haro, J. Bertsch, C. Reed, et al.
Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study.
J Clin Psychiatry, (2010),
[64.]
I. Forcada, E. Papachristou, M. Mur, T. Christodoulou, J. Jogia, A. Reichenberg, et al.
The impact of general intellectual ability and white matter volume on the functional outcome of patients with Bipolar Disorder and their relatives.
J Affect Disord, (2010),
[65.]
J.R. Calabrese, E. Vieta, R. El-Mallakh, R.L. Findling, E.A. Youngstrom, O. Elhaj, et al.
Mood state at study entry as predictor of the polarity of relapse in bipolar disorder.
Biol Psychiatry, 56 (2004), pp. 957-963
[66.]
F. Kapczinski, E. Vieta, A.C. Andreazza, B.N. Frey, F.A. Gomes, J. Tramontina, et al.
Allostatic load in bipolar disorder: implications for pathophysiology and treatment.
Neurosci Biobehav Rev, 32 (2008), pp. 675-692
[67.]
P. Salvatore, R.J. Baldessarini, M. Tohen, H.M. Khalsa, J.P. Sanchez-Toledo, C.A. Zarate Jr., et al.
McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients.
J Clin Psychiatry, 70 (2009), pp. 458-466
[68.]
L. Mazzarini, I. Pacchiarotti, F. Colom, G. Sani, G.D. Kotzalidis, A.R. Rosa, et al.
Predominant polarity and temperament in bipo- lar and unipolar affective disorders.
J Affect Disord, 119 (2009 Dec), pp. 28-33
[69.]
M. Berk, K. Hallam, G.S. Malhi, L. Henry, M. Hasty, C. Macneil, et al.
Evidence and implications for early intervention in bipolar disorder.
J Ment Health, 19 (2010), pp. 113-126
[70.]
C. López-Jaramillo, J. Lopera-Vásquez, J. Ospina-Duque, J. García, A. Gallo, V. Cortez, et al.
Lithium treatment effects on the neu- ropsychological functioning of patients with bipolar I disorder.
J Clin Psychiatry, (2010),
[71.]
A. Yildiz, E. Vieta, S. Leucht, R.J. Baldessarini.
Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials.
Neuropsychopharmacology, 36 (2011), pp. 375-389
[72.]
E. Vieta.
Psychiatry: from interest in conflicts to conflicts of interest.
World Psychiatry, 6 (2007), pp. 27-29
[73.]
F. Colom, E. Vieta.
The need for publishing the silent evidence from negative trials.
Acta Psychiatr Scand, 123 (2011), pp. 91-94
Copyright © 2011. SEP y SEPB